Level of chromosomal abnormality in lung cancer may predict immunotherapy response ...Middle East

News by : () -
Patients with non-small cell lung cancer (NSCLC) whose cancer cells have low levels of aneuploidy - an abnormal number of chromosomes - tend to respond better to immune checkpoint inhibitor drugs than patients with higher levels, Dana-Farber Cancer Institute researchers will report at the virtual AACR Annual Meeting 2021.

Hence then, the article about level of chromosomal abnormality in lung cancer may predict immunotherapy response was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Level of chromosomal abnormality in lung cancer may predict immunotherapy response )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار